CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Press Releases
Original article

FDA Announces First Participant Selected for TEMPO for Digital Health Devices Pilot

Neutral
AI Analysis

Summary

The FDA announced the selection of the first manufacturer for its TEMPO (Technology-Enabled Meaningful Patient Outcomes) pilot program for digital health devices. This is a routine regulatory announcement of pilot program participation.

Importance:2/10
Sentiment:
0.00
FDAdigital healthpilot programTEMPO
Related Companies

Read the original article

Published by FDA Press Releases on July 22, 2026 5:57 PM

Read Original